HESTERBIO logo

Hester Biosciences LTD

HESTERBIO·NSE·
2,169.30 -31.20 (-1.42%)
Market Cap1852.20 Cr
PE Ratio33.16
Volume4,700
Day High - Low2210.90 - 2146.00
52W High-Low2683.60 - 1239.30
DocStoX Score
6.0/10
Fair
Fair Value
Sign in to see
ROE
15.90%
Strong
P/E
33.16x
Fair
Debt / Equity
0.19
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day2146
2211
52W1239
2684
DocStoX take

Supported by risk (8.4) and quality (7.4), but held back by valuation (1.8). Risk looks strong at 8.4, but that is offset by valuation at 1.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.0
/10
Fair
Quality
Solid
ROE 15.9%
Valuation
Expensive
P/E 33.2×
Growth
Steady
Revenue +9.3% 5Y CAGR
Risk
Low risk
D/E 0.19
Momentum
Firm
64% of 52-week range

At a glance

Market Cap
₹1,852 Cr
52W High / Low
₹2684 / ₹1239
Dividend Yield
0.48%
Promoter Holding
53.73%
EPS (TTM)
₹65.41
Book Value
₹423.00

Key highlights

  • Low leverage — D/E 0.19
  • Profitable in all of the last 5 years
  • Healthy net margin (17%)
  • Valuation is weak (1.8/10)
3 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

HESTER BIOSCIENCES LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.